1937 (1937) Fair Value & Analysis

Industrials · Market cap HK$130M

1 1937 1937 · HK

PriceHK$0.1300

Fair ValueHK$0.1200

Upside-7.7%

Quality44/100

Watch 1937 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.1100 – HK$0.1200

Fair value as of: Jul 2, 2026

From 22 valuation models · updated today

Share price −32.3% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1300 – HK$0.3300 · fair‑value band HK$0.1100 – HK$0.1200 · the HK$0.1300 price screens above the HK$0.1200 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1937 (1937) currently trades at HK$0.1300, while our model-based Fair Value estimate is HK$0.1200 — implying the stock looks roughly 7.7% overvalued today. We read business quality at 44/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 1937 generated revenue of HK$190M at a net margin of 2.0%. Revenue declined 27.3% year over year. It earns a return on equity of 1.2%. Net debt stands at HK$6.1M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$190M

Revenue growth (YoY) -27.3%

Net margin 2.0%

Return on equity 1.2%

Free cash flow HK$31.2M FY2025

Operating margin 4.8%

More key figures

EPS growth (YoY) +66.5%

Net debt HK$6.1M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1937 reported revenue of HK$190M in FY2025 versus HK$275M in FY2021, a compound −8.9%/yr. Reported net income was HK$3.8M in FY2025, compounding −37.3%/yr from FY2021.

Revenue −8.9%/yr

FY21 HK$275M

FY22 HK$227M

FY23 HK$235M

FY24 HK$258M

FY25 HK$190M

Net income −37.3%/yr

FY21 HK$24.5M

FY22 HK$10.7M

FY23 HK$5.9M

FY24 HK$11.9M

FY25 HK$3.8M

Is 1937 fairly valued? → Check now

Similar stocks

6 more Building Products & Equipment stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Trane Technologies plc TT	$491.59	$210.11	-57%
Johnson Controls International plc JCI	$148.21	$39.05	-74%
Carrier Global Corporation CARR	$67.97	$16.28	-76%
Compagnie de Saint-Gobain S.A CODGF	$89.95	$106.78	+19%
Daikin Industries,Ltd. DKILF	$138.86	$132.61	-5%
Geberit AG GBERF	$661.46	$368.56	-44%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1937 (1937) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1200 versus a price of HK$0.1300 — about −8% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1937?

Our model-based fair value for 1937 is HK$0.1200 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1300.

What is the quality score of 1937?

1937 has a Quality Score of 44/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1937 (1937)?

1937 reported trailing-twelve-month revenue of about HK$190M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1937?

The net profit margin of 1937 is about 2.0%, meaning it keeps roughly 2.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.